Инвестиционный фонд Kedaara Capital вложил 200 млн долларов в индийского лидера ортопедии Tynor

Home grown private equity firm Kedaara Capital announced a strategic investment of $ 200 million in Tynor Orthotics Private Limited , a leading doctor-recommended orthopaedic supports, mobility aids and rehabilitation solutions brand, on August 25. Details of the stake acquired by Kedaara Capital were not officially disclosed, but a source in the know told Moneycontrol that Kedaara Capital will pick up a majority stake as part of the transaction, which will provide an exit to investor Lighthouse Funds. Founded in 1993, Tynor - which uniquely positioned at the intersection of med-tech and everyday consumer health - has grown into India’s #1 doctor recommended brand in orthopaedic supports, mobility aids, rehabilitation and sports performance enhancement solutions with an extensive reach spanning over 300,000 retail outlets and 8,000 hospitals across 60 countries, the announcement said. It added, “Tynor operates three state-of-the-art facilities across 6.5 lac sq. ft. with its best-in-class lean manufacturing capabilities to deliver global-grade products at competitive prices. Kedaara will work closely with the promoters, Dr. PJ Singh and AJ Singh, the professional management team and long-standing strategic partner Thuasne® to build a leading ortho-focused wellness platform — deepening the brand's reach across India, expanding its presence in international markets, and continuing to invest in world-class, efficient manufacturing, as the company enters its next phase of growth.” Dr. PJ Singh and AJ Singh, promoters of Tynor, said, “With an absolute pride and a heart full of joy, we welcome, Kedaara Capital. Big aspiration of Tynor to become the leader of global south and an indispensable supply chain partner for Global north shall now be achieved by having Kedaara as a partner. Kedaara has an illustrious history of great performance and a team of highly competent and motivated operating partners. Agility of Kedaara and robust process approach of Tynor shall bring an unprecedented trajectory of growth. Kedaara would further augment what Thuasne initiated and Lighthouse nurtured. We are excited, indeed.” Elaborating on the deal, Sunish Sharma, founder and Managing Partner, Kedaara Capital, said, "India's medical devices sector is among the fastest-growing in the world, and Tynor represents a rare opportunity to partner with a clear category leader in orthopaedic supports and rehabilitation. We have long admired Dr. PJ Singh and AJ Singh for building a company anchored in strong values, robust systems and disciplined processes. We are privileged to partner with them and Thuasne® to unlock Tynor's full potential." Elizabeth Ducottet, chairman of the Thuasne® Group, said: "Our partnership with Tynor began more than fifteen years ago, driven by a shared belief in the potential of the Indian market and a common ambition to make high-quality orthopaedic solutions accessible to more patients. Since then, we have seen Tynor develop into an outstanding company and a recognised leader in India." Rochelle Dsouza, Partner, Lighthouse Funds, said, "It has been a privilege to partner with Dr. PJ Singh, AJ Singh and the Tynor team over the past eight years. Their commitment to product quality, and to the doctors and patients they serve, is what has made Tynor the leader it is today. We wish the Company and its new partners at Kedaara every success in the years ahead." Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated! Find the best of Al News in one place, specially curated for you every weekend. Stay on top of the latest tech trends and biggest startup news.